Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation

Dardas Z., Harrold L., Calame D. G., Salter C. G., Kikuma T., Guay K. P., ...Daha Fazla

American Journal of Human Genetics, cilt.112, sa.5, ss.1139-1157, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 112 Sayı: 5
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1016/j.ajhg.2025.03.018
  • Dergi Adı: American Journal of Human Genetics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, International Bibliography of Social Sciences, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, Veterinary Science Database, Nature Index
  • Sayfa Sayıları: ss.1139-1157
  • Anahtar Kelimeler: autosomal recessive, congential disorder of glycosylation, microcephaly, MOGS, monogenic disorder, N-linked glycosylation, neurodevelopmental disorder, UDP-glucose:glycoprotein glucosyltransferase 1, UGGT1
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Congenital disorders of glycosylation (CDGs) comprise a large heterogeneous group of metabolic conditions caused by defects in glycoprotein and glycolipid glycan assembly and remodeling, a fundamental molecular process with wide-ranging biological roles. Herein, we describe bi-allelic UGGT1 variants in fifteen individuals from ten unrelated families of various ethnic backgrounds as a cause of a distinctive CDG of variable severity. The cardinal clinical features of UGGT1-CDG involve developmental delay, intellectual disability, seizures, characteristic facial features, and microcephaly in the majority (9/11 affected individuals for whom measurements were available). The more severely affected individuals display congenital heart malformations, variable skeletal abnormalities including scoliosis, and hepatic and renal involvement, including polycystic kidneys mimicking autosomal recessive polycystic kidney disease. Clinical studies defined genotype-phenotype correlations, showing bi-allelic UGGT1 loss-of-function variants associated with increased disease severity, including death in infancy. UGGT1 encodes UDP-glucose:glycoprotein glucosyltransferase 1, an enzyme critical for maintaining quality control of N-linked glycosylation. Molecular studies showed that pathogenic UGGT1 variants impair UGGT1 glucosylation and catalytic activity, disrupt mRNA splicing, or inhibit endoplasmic reticulum (ER) retention. Collectively, our data provide a comprehensive genetic, clinical, and molecular characterization of UGGT1-CDG, broadening the spectrum of N-linked glycosylation disorders.